Zoster-064
Research payments
$404,522
Through program year 2020, $404,522 in research payments was reported against Zoster-064, across 104 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $8,700 | 2 |
| 2019 | Research | $395,822 | 102 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mary Beth Manning Cleveland, OH Named on 19 payments
- Robert Rosen Winston Salem, NC Named on 6 payments
- Matthew Finneran Akron, OH Named on 5 payments
- Michael Adams Sandy, UT Named on 5 payments
- Ernie Riffer Phoenix, AZ Named on 5 payments
- Sylvia Shoffner Cary, NC Named on 4 payments
- Gerald Shockey Mesa, AZ Named on 4 payments
- Cecil Farrington Salisbury, NC Named on 4 payments
- Jonathan Wilson Winston Salem, NC Named on 4 payments
- Richard Mills Mt Pleasant, SC Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.